A heterogenous population of normal myeloid cells trapped in intermediate stages of differentiation, MDS cells accumulate in the blood, lymph nodes and at tumor sites in virtually all cancer patients.

It is a group of diseases that affect how blood cells are made. In all subtypes of MDS, a chronic bone marrow problem leads to low levels of blood cells moving around in your bloodstream. Fred Hutch ...

Plus, our Resources for Life After Cancer program offers individual and family counseling, lectures, support groups, and practical guidance on employment and insurance issues, among other services.

(Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ... to R289 for the treatment of myelodysplastic syndromes (MDS). R289 1, Rigel's potent ...